SEC Form 4 · accession 0001387131-18-004026
Corindus Vascular Robotics, Inc. · CVRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis A Cannon
Director
Period of report
Aug 10, 2018
Accepted (ET)
Aug 14, 2018 · 9:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Aug 10, 2018 | P | 20,500 | $0.9639 | A | 168,408 | D | |
| Common StockF2,F4 | Aug 13, 2018 | P | 10,500 | $0.95 | A | 178,909 | D | |
| Common StockF5 | holding | — | — | — | 7,557,436 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9527 to $0.9771, inclusive. The reporting person undertakes to provide to Corindus Vascular Robotics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F2Includes 53,326 shares of common stock related to restricted stock units ("RSUs") granted as part of the director's 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to the reporting person's continuous service with Corindus through each such vesting date.
- F387,801 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.
- F498,301 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.
- F5Consists of securities directly owned by BioStar Ventures III, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III, L.P. and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.